Cluster of urinary tract infections due to XDR Pseudomonas aeruginosa. Dr Marie Hallin Service de Microbiologie Hôpital Erasme

Similar documents
Urinary Tract Infections

ANTIBIOTICS IN SEPSIS

Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7

Prevalence of Metallo-β-lactamases Encoding Genes Among Pseudomonas

Date: November 30, 2010

Urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae

Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products

Comparison of effectiveness of sterile vs. clean technique for indwelling catheter care in preventing urinary tract infection

How To Treat Mrsa From A Dead Body

HUSRES Annual Report 2010 Martti Vaara

Urinary Tract Infection and Asymptomatic Bacteriuria Guidance

GUIDELINES EXECUTIVE SUMMARY

A PRINTED copy of this guideline may not be the most recent version. The OFFICIAL version is located on IHNET at the Policies & Procedures Home Page

BD Phoenix Automated Microbiology System

HUSRES Annual Report 2008 Martti Vaara.

Intra-abdominal abdominal Infections

Antibiotic Prophylaxis for Short-term Catheter Bladder Drainage in adults. A Systematic Review (Cochrane database August 2013)

An Infusion of Quality and Safety STAT!

growing problem By: Jena Cummins, Doctor of Pharmacy Candidate

Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F Rev.7 /

Management of Extended Spectrum Beta- Lactamase (ESBL) Producing Enterobacteriaceae in health care settings

Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection

Andreas Heddini, MD, PhD. ReAct Action on Antibiotic Resistance

Antimicrobial Stewardship at the Bedside of Patient Care: Clinical Cases

Etiology and treatment of chronic bacterial prostatitis the Croatian experience

Escherichia coli Harboring mcr-1 and bla CTX-M on a Novel IncF Plasmid: First report of. mcr-1 in the USA

How To Treat Mrsa In Finnish

Catheter-Associated Urinary Tract Infection (CAUTI) Prevention. Basics of Infection Prevention 2 Day Mini-Course 2013

Transformation Protocol

A Practical Guide to Diagnosis and Treatment of Infection in the Outpatient Setting Diagnosis and Treatment of Urinary Tract Infections

THE INCIDENCE OF NOSOCOMIAL URINARY TRACT INFECTIONS: KENYATTA NATIONAL HOSPITAL - INTENSIVE CARE UNIT

Prevention of Nosocomial Infections with KLEANIK Self - Disinfecting Drain Trap

Urinalysis and Body Fluids CRg. Automation: Introduction. Urine Automation. published by Bayer. Unit 3. Chemical Examination of Urine

EDUCATIONAL COMMENTARY RED BLOOD CELLS AND WHITE BLOOD CELLS IN URINALYSIS

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor

Helsingin ja Uudenmaan alueen herkkyystilastoja

Global Spread of Carbapenemase- Producing Klebsiella pneumoniae

Dosing information in renal impairment

Test Method for the Continuous Reduction of Bacterial Contamination on Copper Alloy Surfaces

Nosocomial Bloodstream Infections in Brazilian Hospitals: Analysis of 2,563 Cases from a Prospective Nationwide Surveillance Study

Title: Microbiology Urine Screening Effective date: 05/08/2013. Summary of Significant Changes at this Revision

Solid Organ Transplantation

Reducing the HAI Risk Attributable to Hospital Suction Canisters: An Evidence Based Approach

An Introduction to LEAN

TREATMENT OF PERITONEAL DIALYSIS (PD) RELATED PERITONITIS. General Principles

EMERGENCY MEDICINE IN DISASTER PLANNING

HUSRES Annual Report 2015

The 14th EURL-AR Proficiency Test - enterococci, staphylococci and E. coli Lina Cavaco Susanne Karlsmose Rene S. Hendriksen Frank M.

Hot Topics In Infection Control!

Three-level Response Alert System & Infection Control in the Community

Determination of minimum inhibitory concentrations. Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham B18 7QH, UK

Appropriate Urinary Catheter Use and Management

VUMC Guidelines for Management of Indwelling Urinary Catheters. UC Access/ Maintenance

Service Availability and Readiness Assessment (SARA)

UNIVERSITY OF CONNECTICUT HEALTH CENTER CORRECTIONAL MANAGED HEALTH CARE POLICY AND PROCEDURES FOR USE WITHIN THE CONNECTICUT DEPARTMENT OF CORRECTION

A Safe Patient. Commonwealth Nurses Federation. Jill ILIFFE Executive Secretary. Commonwealth Nurses Federation

Note. 2.0 Background. 1.0 Introduction RECOMMENDATION

Safety FIRST: Infection Prevention Tips

South East of Process Main Building / 1F. North East of Process Main Building / 1F. At 14:05 April 16, Sample not collected

NATIONAL INSTITUTE OF HEALTH AND FAMILY WELFARE. One Year Certificate Course in Hospital Management. (Batch )

Received 22 March 2006/Returned for modification 2 May 2006/Accepted 14 September 2006

TEST METHOD VERIFICATION AND VALIDATION

Maryland County Health Department Tuberculosis Infection Control Plan

Analysis of Klebsiella Outbreak in Neonatal Nursery at Mahatma Ghandi Hospital. Final report

A Real Application of Visual Analytics for Healthcare Associated Infections

Version 12 May BSAC Methods for Antimicrobial Susceptibility Testing. All enquiries to: Mandy Wootton.

APPENDIX B: UWHC SURGICAL ANTIMICROBIAL PROPHYLAXIS GUIDELINES

ABSTRACT. CFU/ml in case of air water syringe, log 10 CFU/ml in case of high speed air turbine hand-piece and log 10

Acinetobacter baumannii is a

Welcome and Instructions

ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES

NewYork-Presbyterian Hospital Sites: Columbia University Medical Center Guideline: Medication Use Manual Page 1 of 12

Disc Diffusion Susceptibility Methods

Section. 37Renal Dialysis Facility

Long-term urinary catheters: prevention and control of healthcare-associated infections in primary and community care

Optimizing Antimicrobial Susceptibility Test Reporting

Laboratory Biosafty In Molecular Biology and its levels

Antibiotikaanvändning

British Society for Antimicrobial Chemotherapy

Practice Guidelines for the Management of Bacterial Meningitis

Diagnostic Techniques: Urine Culture

Beta-lactam antibiotics - Cephalosporins

Pyelonephritis: Kidney Infection

Antibiotic resistance does it matter in paediatric clinical practice? Jette Bangsborg Department of Clinical Microbiology Herlev Hospital

UNIVERSITY OF KENTUCKY HOSPITAL LABORATORIES 3/26/14 Lexington, KY Page 1 of 6

Helsingin ja Uudenmaan alueen herkkyystilastoja

NCLEX Sample Questions

An Overview of Legionella Analyses By Diane Miskowski, MPH EMSL Analytical, Inc. October 2014

Drug Utilization and Evaluation of Cephalosporin s At Tertiary Care Teaching Hospital, Bangalore

Status: Standard Procedure: specifies the procedures to be followed, only in exceptional circumstances should these not be followed

North Carolina Statewide Program for Infection Control and Prevention (SPICE) Objectives. Healthcare-Associated Infections: Impact

Beta-Lactamase Encoding Gene Among Extended Spectrum B-Lactamase Positive Wound Isolates of Pseudomonas

Practice Guidelines. Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections

Urinalysis and Body Fluids CRg

Advice for Colleges, Universities, and Students about Ebola in West Africa For Colleges and Universities

Traffic Patterns in the OR: Has it Become a Super Highway?

Microbiological Testing of the Sawyer Mini Filter. 16 December Summary

Michigan Urological Surgery Improvement Collaborative (MUSIC) Prostate Biopsy Toolkit MUSIC

Management of Catheters Infectious Diseases Working Party/Nurses Group

Transcription:

Dr Marie Hallin Service de Microbiologie Hôpital Erasme

ULB-Hôpital Erasme: 800 beds Nephrology/Renal transplantation 3300 urines/month

15/05/10-2 Urines 13/05/10: BG100504717 (M) 1946 ER WBC: 123/µL RBC: 4/µL Bacteria <3500/µL 75.000 CFU/ml P.aeruginosa BG100504757 (F) 1957 - Neurochir WBC : 20/µL RBC : 10/µL Bacteria <3500/µL 100.000 CFU/ml P.aeruginosa?Inversion error during sample process?

A few days later.. AST Sediment analysis results (/µl) Date of sampling Hospitalization Unit 2 further cases Outbreak? Pipe-tazo Catzidime Cefepime Aztreonam Imipenem Meropenem Gentamicin Amikacin Tobramycin Ciprofloxacin Colistin WBC RBC Bacteria 13/05/10 Neurosurgery R R R R R R R S R R S 20 10 <3500 10 5 Infection control alert Semiquantitative culture (CFU/mL) 13/05/10 ER R R R R R R R S R R S 123 4 <3500 7.5 10 4 17/05/10 Outpatient R R R R R R R S R R S 65 123 77429 10 5 17/05/10 ICU R R R R I R R S R R S 142 290 9225 7.5 10 4

Outbreak? 1 st Case definition: patients with positive culture for P. aeruginosa ceftazidime, imipenem, meropenem and ciprofloxacin I/R No increase in the frequency of XDR P. aeruginosa in non-urine samples 6 5 4 3 Urines Other 2 1 0 4 jan 18 jan 5 avr 19 avr 3 mai 17 mai 31 mai 14 juin 28 juin 12 juil Nb of culture positive for P. aeruginosa ceftazidime, imipenem, meropenem and ciprofloxacin I/R 26 juil

Pseudo-outbreak? No epidemiological link between patients Dissociation between ECBU/semi-quantitative culture bacterial count AST Sediment analysis results (/µl) Date of sampling Hospitalization Unit Pipe-tazo Catzidime Cefepime Aztreonam Imipenem Meropenem Gentamicin Amikacin Tobramycin Ciprofloxacin Colistin WBC RBC Bacteria 13/05/10 Neurosurgery R R R R R R R S R R S 20 10 <3500 10 5 Semiquantitative culture (CFU/mL) 13/05/10 ER R R R R R R R S R R S 123 4 <3500 7.5 10 4 17/05/10 Outpatient R R R R R R R S R R S 65 123 77429 10 5 17/05/10 ICU R R R R I R R S R R S 142 290 9225 7.5 10 4

Pseudo-Outbreak Analytical contamination? Standard Procedure: Collection in sterile containers transferred (vacuum system) in sterile tubes Semi-quantitative urinoculture on CLED medium Sediment analysis - UF1000i Urine flow cytometry analyser (Sysmex) Dipstick - Aution Max AX-4280 (Menarini)

Pseudo-Outbreak Analytical contamination? Sampling of the analysers: Vacutainer sterile tubes (n=6) filled with Schaedler broth Semi-quantitative culture on CLED medium Processed as routine urine samples serially and in parallel on both analysers (UF1000i and/or Aution max) Semi-quantitative culture on CLED medium 1 2

Prospective and Retrospective Search of Cases AST Sediment analysis results (/µl) 2d Case definition: patients with urinoculture positive (>104 CFU/ml) for P. aeruginosa ceftazidime, imipenem, meropenem and ciprofloxacin I/R 23 cases included from 01/01 to 31/07 Date of sampling Hospitalization Unit Pipe-tazo Ctazidime Cefepime Aztreonam Imipenem Meropene Gentamici Amikacin Tobramyci Ciprofloxa Colistin VIM WBC RBC Bacteria Semi-quantitative culture (CFU/mL) 01/01/10 Nephrolgy S I S I R R S S I R S + 19 26 <3500 2 10 4 08/01/10 Nephrolgy R R R S R R S I R R S + 12 7 <3500 >10 5 13/04/10 Pneumology S I I S R R S R R R S + 15 12 <3500 2 10 4 13/05/10 Neurosurgery R R R R R R R S R R S + 20 10 <3500 10 5 13/05/10 ER R R R R R R R S R R S + 123 4 <3500 7.5 10 4 17/05/10 Outpatient R R R R R R R S R R S + 65 123 77429 10 5 17/05/10 ICU R R R R I R R S R R S + 142 290 9225 7.5 10 4 18/05/10 ICU S I I S R R S R R R S + 62 111 <3500 10 5 19/05/10 Outpatient R R R R R R R S R R S + 5 7 <3500 7.5 10 4 28/05/10 Outpatient R R R R R R R S R R S + 25 7 <3500 >10 5 28/05/10 Urology R R R R R R R S R R S + 5927 8934 <3500 105 31/05/10 Surgery R R R R R R R S R R S + 2 21 <3500 5 10 4 07/06/10 ICU R R R R R R R S R R S + 195 199 <3500 7.5 10 4 11/06/10 R R R R R R R S R R S + 564 84 43419 >10 5 16/06/10 Outpatient R R R R R R R S R R S ND 17 47 <3500 10 5 17/06/10 Outpatient R R R R R R R S R R S ND 576 15 3673 5 104 18/06/10 ER R R R R R R R S R R S ND 63 28 <3500 105 18/06/10 ER R R R R R R R S R R S ND 17 16 <3500 >10 5 08/07/10 Urology R R R R R R R R R R S - 20613 498 59712 5 10 4 11/07/10 ER R R R R R R R S R R S + 5990 336 <3500 5 10 4 16/07/10 Gastrology R R R R R R S I R R S + 758 71 <3500 5 10 4 26/07/10 Gynecology R R R R R R R S R R S + 211 46 <3500 10 4 11/07/10 ICU R R R R R R R S R R S + 5 40 <3500 7.5 10 4

Typing Results 16 clinical isolates + isolate from the UF1000i: Same XDR AST profile Same PFGE type (clinical isolates =13) 6 clinical isolates unrelated 40 60 80 100 Date of sampling Hospitalization Unit Piperacillin-tazobactam Ctazidime Cefepime Aztreonam Imipenem Meropenem Gentamicin Amikacin Tobramycin Ciprofloxacin Colistin 16/06/10 Outpatient R R R R R R R S R R S ND ND ND 17/06/10 Outpatient R R R R R R R S R R S ND ND ND 18/06/10 ER R R R R R R R S R R S ND ND ND 18/06/10 ER R R R R R R R S R R S ND ND ND 31/05/10 Surgery R R R R R R R S R R S + - ZT4 11/07/10 ER R R R R R R R S R R S + - ZT4 28/05/10 Outpatient R R R R R R R S R R S + - ZT4 07/06/10 ICU R R R R R R R S R R S + - ZT4 26/07/10 Gynecology R R R R R R R S R R S + - ZT4 13/05/10 Neurosurgery R R R R R R R S R R S + - ZT4 11/06/10 R R R R R R R S R R S + - ZT4 11/07/10 ICU R R R R R R R S R R S + - ZT4 13/05/10 ER R R R R R R R S R R S + - ZT4 17/05/10 Outpatient R R R R R R R S R R S + - ZT4 19/05/10 Outpatient R R R R R R R S R R S + - ZT4 28/05/10 Urology R R R R R R R S R R S + - ZT4 17/05/10 ICU R R R R I R R S R R S + - ZT4 UF1000i analyser R R R R R R R S R R S + - ZT4 08/07/10 Urology R R R R R R R R R R S - - FF 13/04/10 Pneumology S I I S R R S R R R S + - X1 18/05/10 ICU S I I S R R S R R R S + - X1 08/01/10 Nephrolgy R R R S R R S I R R S + - X1 01/01/10 Nephrolgy S I S I R R S S I R S + - X1 16/07/10 Gastrology R R R R R R S I R R S + - spor VIM IMP PFGE type

Intervention and Corrective measures Reminder to the team : RESPECT the routine samples process: culture performed BEFORE processing on the analysers Standard PROTECTION procedure (gowns and gloves) Extensive disinfection of the UF100i broad spectrum disinfectant: Virkon (potassium peroxymonosulfate + sulfamic acid + sodium dodecylbenzenesulfonate) Replacement of the mixing device Implementation of : weekly disinfection sterility control procedure

Conclusions Pseudo-outbreak caused by a VIM positive XDR P. aeruginosa clone due to the contamination of the UF1000i cytometric analyser for urinary sediment 16 cases over 2 months 1 Patient received colistin Users of such analysers should be aware that contamination occur Perform regular sterility control procedures of their analyser Culture have to be performed either before the processing on the analyser on a distinct aliquot